Cover Image
Market Research Report

Global Fecal Occult Testing Market 2019-2023

Published by TechNavio (Infiniti Research Ltd.) Product code 369205
Published Content info 122 Pages
Delivery time: 1-2 business days
Price
Back to Top
Global Fecal Occult Testing Market 2019-2023
Published: July 8, 2019 Content info: 122 Pages
Description

About this market

Fecal occult testing is a laboratory test performed to detect the presence of hemoglobin in a stool sample. Technavio's fecal occult testing market analysis considers sales from hospitals, physicians' office laboratories, and clinical diagnostic laboratories. Our analysis also considers the sales of fecal occult testing in Asia, Europe, North America, and ROW. In 2018, the hospitals segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as rising demand for integrated care services will play a significant role in the hospitals segment to maintain its market position. Also, our global fecal occult testing market report looks at factors such as rising geriatric population, increasing prevalence of CRC, and an increasing number of government initiatives for CRC screening tests. However, stringent regulatory guidelines and lack of trained professionals, challenges associated with FOBT, and limited healthcare services in developing countries may hamper the growth of the fecal occult testing industry over the forecast period.

Overview

Rising geriatric population

The increase in the incidence of various diseases is much higher in the elderly population when compared to the younger population. Colon and rectum cancers are most commonly affecting the elderly population. Government and various organizations have taken initiatives in increasing the number of individuals above 50 years of age to undergo colorectal cancer (CRC) screening. This rising geriatric population will lead to the expansion of the global fecal occult testing market at a CAGR of almost 5% during the forecast period.

Growing demand for POC testing

Point of care (POC) testing has improved the ways the clinical and diagnostics procedures are performed. The early detection and early treatment are the most significant strategy which is implemented by various stakeholders. POC testing plays an important role in CRC screening with advantages such as ease of use, minimal maintenance, and requirement of low-skilled laboratory profession to perform the tests. This development is expected to have a positive impact on the overall market growth.

For the detailed list of factors that will drive the fecal occult testing market during the forecast period 2019-2023, click here.

Competitive Landscape

With the presence of a few major players, the global fecal occult testing market is concentrated. Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading fecal occult testing manufacturers, that include Abbott Laboratories, bioMerieux SA, Danaher Corp., Eiken Chemical Co. Ltd., and Quidel Corp.

Also, the fecal occult testing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

Table of Contents
Product Code: IRTNTR31633

TABLE OF CONTENTS

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

  • 2.1 Preface
  • 2.2 Preface
  • 2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 04: MARKET SIZING

  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 06: MARKET SEGMENTATION BY END-USER

  • Market segmentation by end-user
  • Comparison by end-user
  • Hospitals - Market size and forecast 2018-2023
  • Physicians' office laboratories - Market size and forecast 2018-2023
  • Clinical diagnostic laboratories - Market size and forecast 2018-2023
  • Market opportunity by end-user

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2018-2023
  • Europe - Market size and forecast 2018-2023
  • Asia - Market size and forecast 2018-2023
  • ROW - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity

PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 11: MARKET TRENDS

  • Growing demand for POC testing
  • Technological advances in fecal occult tests for CRC screening
  • Availability of a broad range of CRC screening products

PART 12: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption

PART 13: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Abbott Laboratories
  • bioMerieux SA
  • Danaher Corp.
  • Eiken Chemical Co. Ltd.
  • Quidel Corp.

PART 14: APPENDIX

  • Research methodology
  • List of abbreviations
  • Definition of market positioning of vendors

PART 15: EXPLORE TECHNAVIO

List of Exhibits

  • Exhibit 01: Global healthcare market
  • Exhibit 02: Segments of global healthcare market
  • Exhibit 03: Market characteristics
  • Exhibit 04: Market segments
  • Exhibit 05: Market definition - Inclusions and exclusions checklist
  • Exhibit 06: Market size 2018
  • Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions)
  • Exhibit 08: Global market: Year-over-year growth 2019-2023 (%)
  • Exhibit 09: Five forces analysis 2018
  • Exhibit 10: Five forces analysis 2023
  • Exhibit 11: Bargaining power of buyers
  • Exhibit 12: Bargaining power of suppliers
  • Exhibit 13: Threat of new entrants
  • Exhibit 14: Threat of substitutes
  • Exhibit 15: Threat of rivalry
  • Exhibit 16: Market condition - Five forces 2018
  • Exhibit 17: End-user - Market share 2018-2023 (%)
  • Exhibit 18: Comparison by end-user
  • Exhibit 19: Hospitals - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 20: Hospitals - Year-over-year growth 2019-2023 (%)
  • Exhibit 21: Physicians' office laboratories - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 22: Physicians' office laboratories - Year-over-year growth 2019-2023 (%)
  • Exhibit 23: Clinical diagnostic laboratories - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 24: Clinical diagnostic laboratories - Year-over-year growth 2019-2023 (%)
  • Exhibit 25: Market opportunity by end-user
  • Exhibit 26: Customer landscape
  • Exhibit 27: Market share by geography 2018-2023 (%)
  • Exhibit 28: Geographic comparison
  • Exhibit 29: North America - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 30: North America - Year-over-year growth 2019-2023 (%)
  • Exhibit 31: Europe - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 32: Europe - Year-over-year growth 2019-2023 (%)
  • Exhibit 33: Asia - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 34: Asia - Year-over-year growth 2019-2023 (%)
  • Exhibit 35: ROW - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 36: ROW - Year-over-year growth 2019-2023 (%)
  • Exhibit 37: Key leading countries
  • Exhibit 38: Market opportunity
  • Exhibit 39: Impact of drivers and challenges
  • Exhibit 40: Vendor landscape
  • Exhibit 41: Landscape disruption
  • Exhibit 42: Vendors covered
  • Exhibit 43: Vendor classification
  • Exhibit 44: Market positioning of vendors
  • Exhibit 45: Abbott Laboratories - Vendor overview
  • Exhibit 46: Abbott Laboratories - Business segments
  • Exhibit 47: Abbott Laboratories - Organizational developments
  • Exhibit 48: Abbott Laboratories - Geographic focus
  • Exhibit 49: Abbott Laboratories - Segment focus
  • Exhibit 50: Abbott Laboratories - Key offerings
  • Exhibit 51: bioMerieux SA - Vendor overview
  • Exhibit 52: bioMerieux SA - Business segments
  • Exhibit 53: bioMerieux SA - Organizational developments
  • Exhibit 54: bioMerieux SA - Geographic focus
  • Exhibit 55: bioMerieux SA - Key offerings
  • Exhibit 56: Danaher Corp. - Vendor overview
  • Exhibit 57: Danaher Corp. - Business segments
  • Exhibit 58: Danaher Corp. - Organizational developments
  • Exhibit 59: Danaher Corp. - Geographic focus
  • Exhibit 60: Danaher Corp. - Segment focus
  • Exhibit 61: Danaher Corp. - Key offerings
  • Exhibit 62: Eiken Chemical Co. Ltd. - Vendor overview
  • Exhibit 63: Eiken Chemical Co. Ltd. - Business segments
  • Exhibit 64: Eiken Chemical Co. Ltd. - Organizational developments
  • Exhibit 65: Eiken Chemical Co. Ltd. - Geographic focus
  • Exhibit 66: Eiken Chemical Co. Ltd. - Key offerings
  • Exhibit 67: Quidel Corp. - Vendor overview
  • Exhibit 68: Quidel Corp. - Business segments
  • Exhibit 69: Quidel Corp. - Organizational developments
  • Exhibit 70: Quidel Corp. - Geographic focus
  • Exhibit 71: Quidel Corp. - Key offerings
  • Exhibit 72: Validation techniques employed for market sizing
  • Exhibit 73: Definition of market positioning of vendors
Back to Top